Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets (Parenthetical)

v3.25.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 941,760 $ 1,004,563
Loans, allowance for credit losses 69,903 70,147
Face amount of subordinated debentures 135,995 136,800
Unamortized discount and debt issuance costs $ 5,532 $ 6,162
Preferred stock par value (in USD per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in USD per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 34,287,779 34,151,464
Common stock outstanding (shares) 29,894,757 30,195,999
Accumulated other comprehensive loss, tax benefit $ 17,822 $ 28,576
Treasury stock (shares) 4,393,022 3,955,465